C9-SMs showed elevated levels of secreted interleukin-6 (IL-6) and IL-8 compared to control (CTRL) SMs, reflecting a C9-ALS neuroinflammatory signature. The gene discussed is IL6; the disease is amyotrophic lateral sclerosis.